FDA 483 - eResearch Technology Inc. (dba Clario) - February 27, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Bioclinica Inc. / Clario in Shanghai, China, a Contract Research Organization, revealed significant deficiencies in computer system validation and data integrity practices. The firm failed to validate software used for clinical investigation data, leading to critical data integrity gaps and an inability to ensure the accuracy and reliability of clinical trial data. These issues included missing audit trails, unauthorized modifications, and improper data transfers affecting multiple subjects.
ID · 7ceb26c8-bd99-4133-be24-0728ed5e5bc0